Enterics for Global Health (EFGH)
Conditions: Shigella; Child; Diarrhea Intervention: Sponsors: University of Washington; Aga Khan University; International Centre for Diarrhoeal Disease Research, Bangladesh; University of Maryland, Baltimore; University of Virginia; Asociacion Benefica Prisma; Medical Research Council Unit, The Gambia; Kenya Medical Research Institute; Center for Vaccine Development - Mali; Malawi-Liverpool-Wellcome Trust Clinical Research Programme; Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Enterics for Global Health (EFGH)
Conditions: Shigella; Child; Diarrhea Sponsors: University of Washington; Aga Khan University; International Centre for Diarrhoeal Disease Research, Bangladesh; University of Maryland, Baltimore; University of Virginia; Asociacion Benefica Prisma; Medical Research Council Unit, The Gambia; Kenya Medical Research Institute; Center for Vaccine Development - Mali; Malawi-Liverpool-Wellcome Trust Clinical Research Programme; Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
InvaplexAR-Detox and dmLT Adjuvant in the Netherlands and Zambia
Conditions: Shigellosis; Bacillary Dysentery Interventions: Biological: 2.5 μg InvaplexAR-Detox; Biological: 2.5 μg InvaplexAR-Detox with 0.1 μg of dmLT; Biological: 10 μg InvaplexAR-Detox; Biological: 10 μg InvaplexAR-Detox with 0.1 μg of dmLT; Biological: Placebo Sponsors: Leiden University Medical Center; Centre for Infectious Disease Research in Zambia; PATH; Walter Reed Army Institute of Research (WRAIR); Göteborg University; European Vaccine Initiative; European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (S...
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
InvaplexAR-Detox and dmLT Adjuvant in the Netherlands and Zambia
Conditions: Shigellosis; Bacillary Dysentery Interventions: Biological: 2.5 μg InvaplexAR-Detox; Biological: 10 μg InvaplexAR-Detox; Biological: 0.1 μg of dmLT; Biological: Placebo Sponsors: Leiden University Medical Center; Centre for Infectious Disease Research in Zambia; PATH; Walter Reed Army Institute of Research (WRAIR); Göteborg University; European Vaccine Initiative; European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
InvaplexAR-Detox and dmLT Adjuvant in the Netherlands and Zambia
Conditions: Shigellosis; Bacillary Dysentery Interventions: Biological: 2.5 μg InvaplexAR-Detox; Biological: 2.5 μg InvaplexAR-Detox with 0.1 μg of dmLT; Biological: 10 μg InvaplexAR-Detox; Biological: 10 μg InvaplexAR-Detox with 0.1 μg of dmLT; Biological: Placebo Sponsors: Leiden University Medical Center; Centre for Infectious Disease Research in Zambia; PATH; Walter Reed Army Institute of Research (WRAIR); Göteborg University; European Vaccine Initiative; European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (S...
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
